Literature DB >> 29412501

Region-specific ischemia, neovascularization and macular oedema in treatment-naïve proliferative diabetic retinopathy.

Jason Lange1,2, Majda Hadziahmetovic3, Jingfa Zhang4, Weiye Li1.   

Abstract

IMPORTANCE: Region-specific pathology in proliferative diabetic retinopathy enhances our understanding and management of this disease.
BACKGROUND: To investigate non-perfusion, neovascularization and macular oedema.
DESIGN: A cross-sectional, observational, non-randomized study. PARTICIPANTS: Consecutive 43 eyes of 27 treatment-naïve patients.
METHODS: Ultra-widefield fluorescein angiography for studying specific zones, that is, far-peripheral zone, mid-peripheral zone and central retina (cr), and spectral-domain optical coherence tomography for analysing thickness of macular layers. MAIN OUTCOME MEASURES: Non-perfusion index (NPI) and neovascularization index (NVI) in different zones, thickness of cr, retinal nerve fibre layer, ganglion cell layer (GCL), inner nuclear layer (INL) and outer plexiform layer in parafoveal regions.
RESULTS: The NPI of far-periphery and NVI of mid-periphery were the highest by one-way analysis of variance testing. Ischemic retina defined as high NPI in far-periphery was significantly related to macular oedema via a binary classification approach (P < 0.05). The ischemic retina was correlated with a decreased thickness of both retinal nerve fibre and GCL (P < 0.05); macular oedema was correlated with increased INL thickness (P < 0.0001). CONCLUSIONS AND RELEVANCE: The region-specific correlation of NPI of far-periphery and NVI of mid-periphery, but not with central retinal thickness, suggests different pathogeneses of neovascularization and macular oedema. Retinal nerve fibre layer and GCL, both biomarkers of diabetic retinal neuronopathy, are associated with retinal ischemia, but not with macular oedema, suggesting that diabetic microangiopathy and neuronopathy possess distinct pathogenic pathways. The strong correlation between macular oedema and INL indicates that intracellular oedema is a determining factor of diabetic macular oedema.
© 2018 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  diabetic macular oedema; far-peripheral zone; neovascularization index; non-perfusion index; proliferative diabetic retinopathy

Mesh:

Substances:

Year:  2018        PMID: 29412501     DOI: 10.1111/ceo.13168

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  4 in total

1.  Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced Disease.

Authors:  Gina Yu; Michael T Aaberg; Tapan P Patel; Rahul S Iyengar; Corey Powell; Annie Tran; Caitlin Miranda; Emma Young; Katarina Demetriou; Laxmi Devisetty; Yannis M Paulus
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

2.  Structural retinal changes in cerebral small vessel disease.

Authors:  S Magdalena Langner; Jan H Terheyden; Clara F Geerling; Christine Kindler; Vera C W Keil; Christopher A Turski; Gabrielle N Turski; Charlotte Behning; Maximilian W M Wintergerst; Gabor C Petzold; Robert P Finger
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

3.  Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.

Authors:  Luke Nicholson; Jayashree Ramu; Errol W Chan; James W Bainbridge; Philip G Hykin; Stephen J Talks; Sobha Sivaprasad
Journal:  JAMA Ophthalmol       Date:  2019-06-01       Impact factor: 7.389

4.  Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy.

Authors:  Guo-Tong Xu; Lin Liu; Jingfa Zhang; Tianqin Wang; Chaoyang Zhang; Hai Xie; Mengmeng Jiang; Haibin Tian; Lixia Lu
Journal:  Eye Vis (Lond)       Date:  2021-04-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.